Skip to content

Clinical trials

Phase 1/2 Precursor Cell Lymphoblastic Leukemia-Lymphoma trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Precursor Cell Lymphoblastic Leukemia-Lymphoma Phase: Phase 1/2 Country / region: China Clear all

27 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20152
20166
20173
20181
20213
20221
20231
20245
20255

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting11
Unknown status10
Active, not recruiting4
Completed1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Beijing GoBroad Hospital3
Chinese PLA General Hospital3
PersonGen BioTherapeutics (Suzhou) Co., Ltd.3
Wuhan Sian Medical Technology Co., Ltd3
The First Affiliated Hospital of Soochow University2
Amgen1
AstraZeneca1
Essen Biotech1
Institut de Recherches Internationales Servier (I.R.I.S.)1
MSD R&D (China) Co., Ltd.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Precursor Cell Lymphoblastic Leukemia-Lymphoma27
Leukemia, Lymphocytic, Chronic, B-Cell5
Lymphoma, B-Cell5
Leukemia, Myeloid, Acute4
Lymphoma, Follicular4
Lymphoma, Large B-Cell, Diffuse4
Recurrence4
Leukemia, Prolymphocytic, B-Cell3
Lymphoma3
Lymphoma, Mantle-Cell3

Trials

Showing 1 to 25 of 27. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.